Literature DB >> 6088714

Steroid hormone receptors in human meningiomas, gliomas and brain metastases.

M Poisson, B F Pertuiset, J J Hauw, J Philippon, A Buge, M Moguilewsky, D Philibert.   

Abstract

Progestin, estrogen, androgen, glucocorticoid as well as mineralocorticoid receptors (PR, ER, AR, GR and MR, respectively) were all evaluated with specific synthetic radioligands (biochemical assays) in 25 meningiomas, 9 gliomas and 4 brain metastases. In meningiomas the main steroid hormone receptors appeared to be the progestin receptor, present in 24/25 cases (mean level: 7 105 fmol/gT) and the androgen receptor, present in 23/25 cases (mean level: 2 265 fmol/gT). Progestin receptor levels were found to be significantly lower in meningiomas of the fibroblastic subtype whereas none of the steroid hormone receptors were detected in the anaplastic case. On the other hand, glucocorticoid receptor levels were related to the preoperative glucocorticoid therapy. In gliomas only estrogen receptors (2/9 cases) and especially androgen receptors (8/9 cases) were noticeable: the latter seemed to be related to the histological types and to the sex of patients. No receptors were found in any of the four studied metastases, including one from breast cancer. The biochemical characterization of the receptors as well as their relevance to tumor biology and to the physiology of the normal tissues where tumors arise, were discussed, and biochemical data were compared with those previously reported.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6088714     DOI: 10.1007/bf00165601

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  31 in total

1.  ULTRASTRUCTURE OF MENINGIOMAS AND THE DERIVATION AND NATURE OF THEIR CELLULAR COMPONENTS.

Authors:  L NAPOLITANO; R KYLE; E R FISHER
Journal:  Cancer       Date:  1964-02       Impact factor: 6.860

2.  Glioblastoma multiforme: a clinical survey.

Authors:  J G ROTH; A R ELVIDGE
Journal:  J Neurosurg       Date:  1960-07       Impact factor: 5.115

Review 3.  Unique steroid congeners for receptor studies.

Authors:  T Ojasoo; J P Raynaud
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

4.  [Electron microscope study of nervous system tumors].

Authors:  R Escourolle; J Poirier
Journal:  Neurochirurgie       Date:  1971-05       Impact factor: 1.553

5.  Evidence for a specific mineralocorticoid receptor in rat pituitary and brain.

Authors:  M Moguilewsky; J P Raynaud
Journal:  J Steroid Biochem       Date:  1980-01       Impact factor: 4.292

6.  Histological subtypes and prognostic problems in meningiomas.

Authors:  K Jellinger; F Slowik
Journal:  J Neurol       Date:  1975       Impact factor: 4.849

7.  Estrogen receptor protein in visceral metastases from breast carcinoma.

Authors:  F E Johnson; P P Rosen; C Menendez-Botet; M K Schwartz; R Ashikari; D W Kinne
Journal:  Am J Surg       Date:  1981-08       Impact factor: 2.565

8.  11beta-Methoxy-17-ethynyl-1,3,5(10)-estratriene-3,17beta-diol (moxestrol), a tag for estrogen receptor binding sites in human tissues.

Authors:  J P Raynaud; P M Martin; M M Bouton; T Ojasoo
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

9.  Estrogen-receptor protein in intracranial meningiomas.

Authors:  M S Donnell; G A Meyer; W L Donegan
Journal:  J Neurosurg       Date:  1979-04       Impact factor: 5.115

10.  A study of glucocorticoid receptors in intracranial tumors.

Authors:  Z Y Yu; O Wrange; J Boëthius; A Hatam; L Granholm; J A Gustafsson
Journal:  J Neurosurg       Date:  1981-11       Impact factor: 5.115

View more
  19 in total

1.  Characterization of the influence of anti-hormone and/or anti-growth factor neutralizing antibodies on cell clone architecture and the growth of human neoplastic astrocytic cell lines.

Authors:  I Camby; I Salmon; S Rorive; T Gras; F Darro; A Kruczynski; A Danguy; J L Pasteels; R Kiss
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

2.  Steroid receptor status difference in recurrent intracranial meningioma and breast cancer in the same patient.

Authors:  H Magdelenat; B F Pertuiset; M Poisson; J Philippon
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

3.  Progesterone receptor isoforms expression pattern in human chordomas.

Authors:  I Camacho-Arroyo; G González-Agüero; A Gamboa-Domínguez; M A Cerbón; R Ondarza
Journal:  J Neurooncol       Date:  2000-08       Impact factor: 4.130

4.  Hormonal modulation of brain tumour growth: a cell culture study.

Authors:  N Gibelli; C Zibera; G Butti; R Assietti; G Sica; M Scerrati; F Iacopino; R Roselli; P Paoletti; G Robustelli della Cuna
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

5.  Mifepristone (RU 486) treatment of meningiomas.

Authors:  S W Lamberts; H L Tanghe; C J Avezaat; R Braakman; R Wijngaarde; J W Koper; H de Jong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-06       Impact factor: 10.154

6.  Gonadal steroid receptors in meningiomas.

Authors:  K P Lesch; W Schott; H G Engl; S Gross; P Thierauf
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

Review 7.  The biology of meningiomas.

Authors:  I E McCutcheon
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

8.  Radiolabeled 5-iodo-3'-O-(17beta-succinyl-5alpha-androstan-3-one)-2'-deoxyuridine and its 5'-monophosphate for imaging and therapy of androgen receptor-positive cancers: synthesis and biological evaluation.

Authors:  Zbigniew P Kortylewicz; Jessica Nearman; Janina Baranowska-Kortylewicz
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

9.  A study on the biological behavior of human brain tumors. Part II: Steroid receptors and arachidonic acid metabolism.

Authors:  G Butti; P Gaetani; C Chiabrando; R Assietti; C Zibera; M G Castelli; N Gibelli; V Silvani; G Robustelli della Cuna; P Paoletti
Journal:  J Neurooncol       Date:  1991-06       Impact factor: 4.130

10.  Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States).

Authors:  K P Cantor; C F Lynch; D Johnson
Journal:  Cancer Causes Control       Date:  1993-11       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.